Description: Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. Atomo Diagnostics Limited was founded in 2010 and is headquartered in Leichhardt, Australia.
Home Page: atomodiagnostics.com
AT1 Technical Analysis
3-5 George St
Leichhardt,
NSW
2040
Australia
Phone:
61 2 9099 4750
Officers
| Name | Title |
|---|---|
| Mr. John Michael Kelly | Founder, CEO, MD & Director |
| Mr. William Edward Souter BCom, LLB (Adel), IPAA | Chief Financial Officer |
| Ms. Chandra Sukumar | Chief Operating Officer |
| Mr. Jim P. McMenamy | Head of Bus. Devel. & Partnerships of the Americas |
| Ms. Anna Tucker | Head of Bus. Devel. & Partnerships of Europe, Middle East and Africa |
| Mr. Tharun Kuppanda | Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 54.9451 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2194 |
| Price-to-Sales TTM: | 2.499 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |